Report of Foreign Issuer (6-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2018

 

Commission File No.  000-30087

 

EMPOWER CLINICS INC. (formerly ADIRA ENERGY LTD.)

(Translation of registrant's name into English)

 

1030 West Georgia Street, Suite 918 Vancouver, British Columbia Canada V6E 2Y3

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

 

Form 20-F [X]  Form 40-F [_]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [_]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [_]

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBMITTED HEREWITH

 

Exhibits
99.1	Management’s Discussion and Analysis for the period ended June 30, 2018
99.2	Interim Consolidated Unaudited Financial Statements for the six months ended June 30, 2018
99.3	Form 52-109FV2 - Certification of Interim Filings - CFO
99.4	Form 52-109FV2 - Certification of Interim Filings - CEO

 

 

 

 

 

 

 

 

 

 

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

EMPOWER CLINICS INC. (formerly ADIRA ENERGY LTD.)

 

Date: July 24, 2019

 

/s/ Mathew Lee
Mathew Lee
Chief Financial Officer

 

 

 

 

 

 

 

 

3